An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

Washington University-led research shows a small group of participants in an Alzheimer’s study experienced a significant ...

"They didn't value me as much," the actress says of initially not having the same name recognition as her male co-star The ...

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

A method for slowing disease progress in Alzheimer's patients may also delay onset in people predisposed to the disease who ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

Investigators said that the OLE study showed Roche’s gantenerumab dropped the risk of developing Alzheimer's symptoms by 50%.

The results boost hopes similar treatments being developed to target more common forms of Alzheimer’s – that appear when ...

The findings provide new evidence to support the so-called amyloid hypothesis of Alzheimer's disease, which posits that the ...

Since becoming only the second Alzheimer's-modifying drug to gain American Federal Drug Administration approval in 2023, ...

Researchers claim their study proves it is possible to delay Alzheimer's and 'give people more years of healthy life'.